{"id":"W3164040616","doi":"10.1101/2021.05.27.21257096","title":"Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System","funders":"Vir Biotechnology","keywords":"Placebo; Medicine; Clinical endpoint; Interim analysis; Internal medicine; Adverse effect; Confidence interval; Population; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; Disease; Pathology; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008656234,0.0005124388,0.001588125,0.0002225354,0.0002199741,0.0005382577,0.0004472679,0.0005792505,0.002827322],"category_scores_gemma":[0.0005285451,0.0001665227,0.0009711485,0.000137343,0.0003276989,0.0003726406,0.0002595549,0.001570893,0.0002978934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000328085,"about_ca_system_score_gemma":0.0006114618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002343748,"about_ca_topic_score_gemma":0.0004966569,"domain_scores_codex":[0.9996343,0.000171076,0.00002900026,0.00005290921,0.00004102936,0.00007183537],"domain_scores_gemma":[0.9996445,0.00008436704,0.0001023862,0.00003015783,0.00002337247,0.0001152624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6719701,0.02520122,0.006720219,0.0009232158,0.001129838,0.0001627652,0.000099499,0.001924975,0.0788039,0.0005586876,0.002892127,0.2096135],"study_design_scores_gemma":[0.432463,0.5033326,0.03232983,0.0001796894,0.0008432671,0.0003963066,0.00005999471,0.002687838,0.02138041,0.0005485673,0.005736601,0.00004191962],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991252,0.004851315,0.0008254471,0.0003079105,0.0001771826,0.0005544081,0.0003526803,0.00006229286,0.00161677],"genre_scores_gemma":[0.9952846,0.001273641,0.0009223941,0.0003724354,0.0001603072,0.0005413776,0.0005206275,0.000007473466,0.0009171569],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002827322,"threshold_uncertainty_score":0.009458303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0862114640864935,"score_gpt":0.3971114174822251,"score_spread":0.3108999533957316,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}